SCHEMBL4047674

SCHEMBL4047674

NC(=S)Nc1cccc(NC(N)=S)c1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.76
CYP1A2 P05177 1/20 0.73
ALDH1A1 P00352 5/20 0.70
TP53 P04637 1/20 0.70
TYR P14679 1/20 0.70
TSHR P16473 1/20 0.70
TAS2R38 P59533 1/20 0.70
HSD17B10 Q99714 1/20 0.70
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
HPGD P15428 1/20 0.50
ALOX12 P18054 1/20 0.50
CYP2C19 P33261 1/20 0.50
KDM4E B2RXH2 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GAA P10253 3/20 0.49
NPSR1 Q6W5P4 1/20 0.47
IDO1 P14902 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20057531 0.89 CYP1A2 (0.67) KMT2ACYP1A2ALDH1A1TP53TYR
SCHEMBL28936790 0.87 KMT2A (0.66) KMT2ACYP1A2ALDH1A1TP53TYR
SCHEMBL29654010 0.87 KMT2A (0.66) KMT2ACYP1A2ALDH1A1TP53TYR
SCHEMBL1884582 0.87 KMT2A (1.00) KMT2ACYP1A2ALDH1A1TP53TYR
SCHEMBL29654057 0.86 ALDH1A1 (0.62) KMT2ACYP1A2ALDH1A1TP53TYR
SCHEMBL5459330 0.86 ALDH1A1 (0.62) KMT2ACYP1A2ALDH1A1TP53TYR
SCHEMBL2312439 0.85 KMT2A (0.63) KMT2ACYP1A2ALDH1A1TP53TYR
SCHEMBL653292 0.85 GAA (0.68) KMT2ACYP1A2ALDH1A1TP53TYR
SCHEMBL1886408 0.85 CYP1A2 (1.00) KMT2ACYP1A2ALDH1A1TP53TYR
SCHEMBL29838519 0.85 IDO1 (0.68) KMT2ACYP1A2ALDH1A1TP53TYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032583-B1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed
EP-2032583-B1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
EP-2032583-A1 NEW CHEMICAL COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2009-03-11 EP disclosed
WO-2007144370-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-12-21 WO disclosed
WO-2007144370-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258857-A1 CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 KMT2A 3467/4885CYP1A2 83/4885ALDH1A1 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.